COMMUNIQUÉS West-GlobeNewswire

OSE Immunotherapeutics Provides Business and Corporate Update
30/05/2024
OSE Immunotherapeutics Provides Business and Corporate Update Three pharmaceutical agreements signed during the last three months: New strategic partnership with AbbVie for OSE-230, a novel preclinical potential first- [...]
OSE Immunotherapeutics fait le point sur ses avancées et sur la stratégie de croissance de la Société
30/05/2024
OSE Immunotherapeutics fait le point sur ses avancées et sur la stratégie de croissance de la Société Trois accords pharmaceutiques signés au cours des trois derniers mois : Un nouveau partenariat stratégique avec [...]
Partnership with Key Opinion Leaders and successful trainings
30/05/2024
Press release Ecully, May 30, 2024 – 6 p.m. SPINEWAY organizes surgical training sessions in the use of ESP and KAPHORN implants The Spineway Group, a specialist in innovative implants for the treatment of severe spine [...]
Partenariat et formations chirurgiens
30/05/2024
Communiqué de presse Ecully, le 30 mai 2024 – 18h SPINEWAY organise des sessions de formation chirurgicale à l’utilisation des implants ESP et KAPHORN Le groupe Spineway spécialiste des implants innovants pour le [...]
L’OCCITANE en Provence and CARBIOS present a PET bottle made from enzymatic recycling, the result of a European circular economy
30/05/2024
L’OCCITANE en Provence and CARBIOS present a PET bottle made from enzymatic recycling, the result of a European circular economy CARBIOS, L’OCCITANE en Provence and Pinard Beauty Pack join forces to establish an [...]
L’OCCITANE en Provence et CARBIOS présentent un flacon en PET issu du recyclage enzymatique, fruit d’une filière européenne d’économie circulaire
30/05/2024
L’OCCITANE en Provence et CARBIOS présentent un flacon en PET issu du recyclage enzymatique, fruit d’une filière européenne d’économie circulaire CARBIOS, L’OCCITANE en Provence et Pinard Beauty Pack s’unissent pour la [...]
Spectral Medical Inc. Announces Closing of Approximately C$8.5 Million Convertible Notes Financing
30/05/2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES [...]
EssilorLuxottica: Result of the payment of dividends in shares and record of the corresponding capital increase
30/05/2024
Result of the payment of dividends in shares and record of the corresponding capital increase Charenton-le-Pont, France (May 30, 2024 – 4:30 pm) – The Annual General Meeting of EssilorLuxottica has decided to grant to [...]
EssilorLuxottica: Résultat du paiement du dividende en actions et constatation de l’augmentation de capital correspondante
30/05/2024
Résultat du paiement du dividende en actions et constatation de l’augmentation de capital correspondante Charenton-le-Pont, France (30 mai 2024 - 16h30) – L’Assemblée générale annuelle d’EssilorLuxottica a décidé de [...]
CEO UPDATE
30/05/2024
GRANTS, NEW MEXICO, May 30, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) Dear BGXX Shareholders, I’m writing to you today to share an update on several developments for Bright Green Corporation (“ [...]
BlueSphere Bio to Present Corporate Update and Participate in a Panel Discussion at the 2024 BIO International Convention
30/05/2024
PITTSBURGH, May 30, 2024 (GLOBE NEWSWIRE) -- BlueSphere Bio , a drug development company focused on the discovery of novel T-cell receptor (TCR)-based therapies with a robust clinical pipeline and powerful, high- [...]
ONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 MEETING
30/05/2024
AGOURA HILLS, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its CEO- Dr. Vuong Trieu will be participating at the BIO International 2024 meeting on June3-6, San Diego [...]
Presentation of the Congress of the European Academy of Allergy and Clinical Immunology (EAACI) to be held in Valencia from May 31 to June 3
30/05/2024
VALENCIA, Spain, May 30, 2024 (GLOBE NEWSWIRE) -- Under the theme "Revolutionizing Patient Care through the Power of Data Science," the congress will highlight the crucial role of Allergy and Clinical Immunology in [...]
Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to July 3, 2024
30/05/2024
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ”), a special purpose acquisition company, announced today that it has notified Continental Stock [...]
Privia Health to Participate in the William Blair Growth Stock Conference
30/05/2024
ARLINGTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to present at the 44 th Annual William Blair Growth Stock Conference on Wednesday [...]
AVITA Medical Announces FDA Approval of RECELL GO
30/05/2024
VALENCIA, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]
Biomea Fusion Announces Completion of Enrollment of First 3 Arms in Phase 2 Expansion Cohorts of COVALENT-111 Study for BMF-219 in Type 2 Diabetes
30/05/2024
BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a [...]
Press Release: Sanofi completes acquisition of Inhibrx, Inc.
30/05/2024
Sanofi completes acquisition of Inhibrx, Inc. Paris, May 30, 2024. Sanofi announced today the completion of its acquisition of Inhibrx, Inc . (“Inhibrx”). The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi’s [...]
Communiqué de presse : Sanofi finalise l’acquisition d’Inhibrx, Inc.
30/05/2024
Sanofi finalise l’acquisition d’Inhibrx, Inc. Paris, le 30 mai 2024. Sanofi annonce aujourd’hui la finalisation de son acquisition d’Inhibrx, Inc . (« Inhibrx »). Cette opération ajoute le SAR447537 (anciennement INBRX- [...]

Pages